nt100
Recombinant proteinexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2013 (NCT01864356)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nt100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02156063 | Phase 2 | Jun 1, 2014 | Nora Therapeutics, Inc. |
| NCT01978561 | Phase 2 | Oct 1, 2013 | Nora Therapeutics, Inc. |
| NCT01864356 | Phase 2 | May 1, 2013 | Nora Therapeutics, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Nora Therapeutics, Inc. | For profit | 3 | 3 | 1 | 2013 |
1 organizations
Page 1 / 1